Introduction: The presence of vascular complications at type 2 diabetes (T2D) diagnosis is a heavy burden for developing countries. We aimed to determine the prevalence and correlates of macrovascular complications at T2D diagnosis in Yaoundé, Cameroon. Materials and Methods: We conducted a cross-sectional study at the Essos Hospital Center in Yaoundé from January 2017 to June 2021. We recruited patients newly diagnosed with T2D who, simultaneously, with assessed macrovascular complications including stroke, myocardial infarction (MI) and arterial foot ulcer (AFU). Correlates were investigated using Chi square test and logistic regressions. The significance level was set at 5%. Results: In all, 286 newly diagnosed diabetic patients (51.7% being men) were included. The mean age was 52.6 ± 12.3 years. Prevalent cardiovascular risk factors at diabetes diagnosis were a dyslipidemia (63.6%), sedentary lifestyle (57.7%) and family history of type 2 diabetes (51.6%). The prevalence of macrovascular complications was 17.5% with 8.4% stroke, 5.6% myocardial infarction and 3.4% arterial foot ulcer. Hypertension was associated with all macrovascular complications (p < 0.05). High glycated hemoglobin and age ≥ 50 years were associated with stroke while tobacco and obesity were associated with MI and AFU respectively. Conclusion: Macrovascular complications are frequent at type 2 diabetes diagnosis and are represented by stroke and myocardial infarction in our study, highlighting the importance of cardiovascular risk evaluation and reduction in people with diabetes right from diagnosis.
References
[1]
International Diabetes Federation (2021) IDF Diabetes Atlas (10th Edition). https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.pdf
[2]
Viigimaa, M., Sachinidis, A., Toumpourleka, M., Koutsampasopoulos, K., Alliksoo, S. and Titma, T. (2020) Macrovascular Complications of Type 2 Diabetes Mellitus. Current Vascular Pharmacology, 18, 110-116. https://doi.org/10.2174/1570161117666190405165151
[3]
Fowler, M.J. (2008) Microvascular and Macrovascular Complications of Diabetes. Clinical Diabetes, 26, 77-82. https://doi.org/10.2337/diaclin.26.2.77
[4]
Creager, M.A., Lüscher, T.F., Cosentino, F. and Beckman, J.A. (2003) Diabetes and Vascular Disease. Circulation, 108, 1527-1532. https://doi.org/10.1161/01.CIR.0000091257.27563.32
[5]
Mbanya, J.C. and Sobngwi, E. (2003) Diabetes Microvascular and Macrovascular Disease in Africa. European Journal of Cardiovascular Prevention and Rehabilitation, 10, 97-102. https://doi.org/10.1177/174182670301000204
[6]
Tamba, S.M., Ewane, M.E., Bonny, A., Muisi, C.N., Nana, E., Ellon, A., et al. (2013) Micro and Macrovascular Complications of Diabetes Mellitus in Cameroon: Risk Factors and Effect of Diabetic Check-Up—A Monocentric Observational Study. The Pan African Medical Journal, 15, Article No. 141. https://www.panafrican-med-journal.com/content/article/15/141/full https://doi.org/10.11604/pamj.2013.15.141.2104
[7]
Aikaeli, F., Njim, T., Gissing, S., Moyo, F., Alam, U., Mfinanga, S.G., et al. (2022) Prevalence of Microvascular and Macrovascular Complications of Diabetes in Newly Diagnosed Type 2 Diabetes in Low-and-Middle-Income Countries: A Systematic Review and Meta-Analysis. PLOS Global Public Health, 2, e0000599. https://doi.org/10.1371/journal.pgph.0000599
[8]
Kosiborod, M., Gomes, M.B., Nicolucci, A., Pocock, S., Rathmann, W., Shestakova, M.V., et al. (2018) Vascular Complications in Patients with Type 2 Diabetes: Prevalence and Associated Factors in 38 Countries (the DISCOVER Study Program). Cardiovascular Diabetology, 17, Article No. 150. https://doi.org/10.1186/s12933-018-0787-8
[9]
Sinclair, A. (2019) Sub-Sahara Africa—The Impact and Challenge of Type 2 Diabetes Mellitus Requiring Urgent and Sustainable Public Health Measures. eClinicalMedicine, 16, 6-7. https://doi.org/10.1016/j.eclinm.2019.10.005
[10]
American Diabetes Association (2017) Standards of Medical Care in Diabetes—2017 Abridged for Primary Care Providers. Clinical Diabetes, 35, 5-26. https://doi.org/10.2337/cd16-0067
[11]
Taneja, G.S., Kumar, R., Merwah, R. and Thakur, S. (2018) Frequency of Macro Vascular Complications in Patients of Newly Diagnosed Type 2 Diabets Mellitus and Its Correlation with Major Cardiovascular Risk Factors; A Hospital Based Study. Journal of the Association of Physicians of India, 66, 26-29.
[12]
Sosale, A., Prasanna Kumar, K.M., Sadikot, S.M., Nigam, A., Bajaj, S., Zargar, A.H., et al. (2014) Chronic Complications in Newly Diagnosed Patients with Type 2 Diabetes Mellitus in India. Indian Journal of Endocrinology and Metabolism, 18, 355-360. https://doi.org/10.4103/2230-8210.131184
[13]
Kassi, E., Pervanidou, P., Kaltsas, G. and Chrousos, G. (2011) Metabolic Syndrome: Definitions and Controversies. BMC Medicine, 9, Article No. 48. https://doi.org/10.1186/1741-7015-9-48
[14]
World Health Organization (2010) Global Recommendations on Physical Activity for Health. Geneva. (WHO Guidelines Approved by the Guidelines Review Committee). http://www.ncbi.nlm.nih.gov/books/NBK305057/
[15]
Sacco, R.L., Kasner, S.E., Broderick, J.P., Caplan, L.R., Connors, J.J., Culebras, A., et al. (2013) An Updated Definition of Stroke for the 21st Century. Stroke, 44, 2064-2089. https://doi.org/10.1161/STR.0b013e318296aeca
[16]
Mechanic, O.J., Gavin, M. and Grossman, S.A. (2022) Acute Myocardial Infarction. StatPearls, Treasure Island. http://www.ncbi.nlm.nih.gov/books/NBK459269/
[17]
Spijkerman, A.M.W., Henry, R.M.A., Dekker, J.M., Nijpels, G., Kostense, P.J., Kors, J.A., et al. (2004) Prevalence of Macrovascular disease amongst Type 2 Diabetic Patients Detected by Targeted Screening and Patients Newly Diagnosed in General Practice: The Hoorn Screening Study. Journal of Internal Medicine, 256, 429-436. https://doi.org/10.1111/j.1365-2796.2004.01395.x
[18]
IWGDF Guidelines (2019) IWGDF Guidelines on the Prevention and Management of Diabetic Foot Disease. https://iwgdfguidelines.org/wp-content/uploads/2019/05/IWGDF-Guidelines-2019.pdf
[19]
Morkos, M., Tahsin, B., Fogg, L. and Fogelfeld, L. (2018) Newly Diagnosed Type 2 Diabetes in an Ethnic Minority Population: Clinical Presentation and Comparison to Other Populations. BMJ Open Diabetes Research & Care, 6, e000568. https://doi.org/10.1136/bmjdrc-2018-000568
[20]
Bonora, E., Trombetta, M., Dauriz, M., Travia, D., Cacciatori, V., Brangani, C., et al. (2020) Chronic Complications in Patients with Newly Diagnosed Type 2 Diabetes: Prevalence and Related Metabolic and Clinical Features: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 9. BMJ Open Diabetes Research & Care, 8, e001549. https://doi.org/10.1136/bmjdrc-2020-001549
[21]
Masala, D., Mannocci, A., Sinopoli, A., D’Egidio, V., Villari, P. and La Torre, G. (2017) Physical Activity and Its Importance in the Workplace. Igiene e sanita pubblica, 73, 159-169.
[22]
Przezak, A., Bielka, W. and Pawlik, A. (20220 Hypertension and Type 2 Diabetes—The Novel Treatment Possibilities. International Journal of Molecular Sciences, 23, Article 6500. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224227/ https://doi.org/10.3390/ijms23126500
[23]
Einarson, T.R., Acs, A., Ludwig, C. and Panton, U.H. (2018) Prevalence of Cardiovascular Disease in Type 2 Diabetes: A Systematic Literature Review of Scientific Evidence from across the World in 2007-2017. Cardiovascular Diabetology, 17, Article No. 83. https://doi.org/10.1186/s12933-018-0728-6
[24]
Schernthaner, G. (1996) Cardiovascular Mortality and Morbidity in Type-2 Diabetes Mellitus. Diabetes Research and Clinical Practice, 31, S3-S13. https://doi.org/10.1016/0168-8227(96)01224-7
[25]
An, J., Nichols, G.A., Qian, L., Munis, M.A., Harrison, T.N., Li, Z., et al. (2021) Prevalence and Incidence of Microvascular and Macrovascular Complications over 15 Years among Patients with Incident Type 2 Diabetes. BMJ Open Diabetes Research & Care, 9, e001847. https://doi.org/10.1136/bmjdrc-2020-001847
[26]
Chowdhury, T.A. and Lasker, S.S. (2002) Complications and Cardiovascular Risk Factors in South Asians and Europeans with Early-Onset Type 2 Diabetes. QJM: An International Journal of Medicine, 95, 241-216. https://doi.org/10.1093/qjmed/95.4.241
